Artificial intelligence for clinical decision-making in retinal disorders: From screening and diagnosis to treatment and longitudinal management
Study limitation reported by the research below: “The evidence base across the four disease areas is highly heterogeneous in study design and validation rigor, making cross-condition comparisons difficult.”